02/25/2025
8:26 AM | Nuvectis Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/11/2025
4:58 PM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
5:30 AM | Nuvectis Pharma (Filer)
| Form 424B5 | |
02/05/2025
8:51 PM | Nuvectis Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2025
5:09 PM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
5:10 PM | Carson Michael J. (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
5:12 PM | Nuvectis Pharma (Issuer)
Poradosu Enrique (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
5:13 PM | Nuvectis Pharma (Issuer)
Shemesh Shay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
7:00 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
4:37 PM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4/A | |
12/16/2024
7:00 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2024
7:30 AM | Nuvectis Pharma (Issuer)
Poradosu Enrique (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2024
7:30 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
2:59 PM | Carson Michael J. (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
9:55 AM | Nuvectis Pharma (Subject)
Pontifax Management 4 G.P. Ltd. (0001726334) (Filed by)
| Form SC 13G/A | |
11/05/2024
7:31 AM | Nuvectis Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2024
6:08 AM | Nuvectis Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2024
7:52 AM | Nuvectis Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2024
3:09 PM | Nuvectis Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
8:16 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
7:47 AM | Nuvectis Pharma (Issuer)
Shemesh Shay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
7:49 AM | Nuvectis Pharma (Issuer)
Poradosu Enrique (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
7:51 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
8:13 AM | Nuvectis Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Buy NVCT Stock Free NVCT Stock Alerts